Endocrinopathies Following Allogeneic Stem Cell Transplantation: 10 Years Follow-up in 402 Patients

ConclusionsAllo-HCT survivors are at relevant risk of endocrinopathies after transplantation, providing justification for specific monitoring to individualize treatment and follow-up. Of note, classical transplant-related variables are not enough to justify the occurrence of endocrinological disfunction: a further deeper evaluation of a misdiagnosed donor-mediated autoimmune predisposition will be essential.DisclosuresBonini: Intellia Therapeutics: Research Funding.

Source: Blood - November 21, 2018 Category: Hematology Authors: Lupo Stanghellini, M. T., Vita, G., Assanelli, A., Lorentino, F., Serpenti, F., Greco, R., Marcatti, M., Giglio, F., Xue, E., Casirati, G., Farina, F., Clerici, D., Mastaglio, S., Liberatore, C., Lazzari, L., Piemontese, S., Pavesi, F., Bernardi, M., Pecc Tags: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III Source Type: research